inobrodib
cellcentric
['inobrodib', 'multiple myeloma']
cellcentric at #eha2023. sharing inobrodib clinical data, treating relapsed refractory multiple myeloma. see: 
Inobrodib (CCS1477): first-in-class p300/CBP small molecule inhibitor drug, to treat specific cancers.